Cargando…
Legislative activity related to the human papillomavirus (HPV) vaccine in the United States (2006–2015): a need for evidence-based policy
State-based policies to mandate HPV vaccination are politically challenging and have received broad criticisms. There is a critical need to understand the legislative activities that underpin subsequent policy implementation. The objective of this policy analysis was to analyze state legislation tha...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356918/ https://www.ncbi.nlm.nih.gov/pubmed/28331378 http://dx.doi.org/10.2147/RMHP.S128247 |
_version_ | 1782515948229492736 |
---|---|
author | Keim-Malpass, Jessica Mitchell, Emma M DeGuzman, Pamela B Stoler, Mark H Kennedy, Christine |
author_facet | Keim-Malpass, Jessica Mitchell, Emma M DeGuzman, Pamela B Stoler, Mark H Kennedy, Christine |
author_sort | Keim-Malpass, Jessica |
collection | PubMed |
description | State-based policies to mandate HPV vaccination are politically challenging and have received broad criticisms. There is a critical need to understand the legislative activities that underpin subsequent policy implementation. The objective of this policy analysis was to analyze state legislation that focused on HPV vaccination from 2006–2015. A content analysis was conducted among primary sources of legislative data from HPV vaccine-related bills, including using the National Conference of State Legislatures as a search-source. Findings reveal that much of the legislative activity occurred early after the HPV vaccination was introduced, and focused on increased information for parents, public financing, awareness campaigns, etc. Far fewer states focused on voluntary or mandatory vaccination. Understanding the barriers to achieving mandatory vaccination policy and implementation of such policies for HPV vaccines remains a public health priority. |
format | Online Article Text |
id | pubmed-5356918 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-53569182017-03-22 Legislative activity related to the human papillomavirus (HPV) vaccine in the United States (2006–2015): a need for evidence-based policy Keim-Malpass, Jessica Mitchell, Emma M DeGuzman, Pamela B Stoler, Mark H Kennedy, Christine Risk Manag Healthc Policy Short Report State-based policies to mandate HPV vaccination are politically challenging and have received broad criticisms. There is a critical need to understand the legislative activities that underpin subsequent policy implementation. The objective of this policy analysis was to analyze state legislation that focused on HPV vaccination from 2006–2015. A content analysis was conducted among primary sources of legislative data from HPV vaccine-related bills, including using the National Conference of State Legislatures as a search-source. Findings reveal that much of the legislative activity occurred early after the HPV vaccination was introduced, and focused on increased information for parents, public financing, awareness campaigns, etc. Far fewer states focused on voluntary or mandatory vaccination. Understanding the barriers to achieving mandatory vaccination policy and implementation of such policies for HPV vaccines remains a public health priority. Dove Medical Press 2017-03-13 /pmc/articles/PMC5356918/ /pubmed/28331378 http://dx.doi.org/10.2147/RMHP.S128247 Text en © 2017 Keim-Malpass et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Short Report Keim-Malpass, Jessica Mitchell, Emma M DeGuzman, Pamela B Stoler, Mark H Kennedy, Christine Legislative activity related to the human papillomavirus (HPV) vaccine in the United States (2006–2015): a need for evidence-based policy |
title | Legislative activity related to the human papillomavirus (HPV) vaccine in the United States (2006–2015): a need for evidence-based policy |
title_full | Legislative activity related to the human papillomavirus (HPV) vaccine in the United States (2006–2015): a need for evidence-based policy |
title_fullStr | Legislative activity related to the human papillomavirus (HPV) vaccine in the United States (2006–2015): a need for evidence-based policy |
title_full_unstemmed | Legislative activity related to the human papillomavirus (HPV) vaccine in the United States (2006–2015): a need for evidence-based policy |
title_short | Legislative activity related to the human papillomavirus (HPV) vaccine in the United States (2006–2015): a need for evidence-based policy |
title_sort | legislative activity related to the human papillomavirus (hpv) vaccine in the united states (2006–2015): a need for evidence-based policy |
topic | Short Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356918/ https://www.ncbi.nlm.nih.gov/pubmed/28331378 http://dx.doi.org/10.2147/RMHP.S128247 |
work_keys_str_mv | AT keimmalpassjessica legislativeactivityrelatedtothehumanpapillomavirushpvvaccineintheunitedstates20062015aneedforevidencebasedpolicy AT mitchellemmam legislativeactivityrelatedtothehumanpapillomavirushpvvaccineintheunitedstates20062015aneedforevidencebasedpolicy AT deguzmanpamelab legislativeactivityrelatedtothehumanpapillomavirushpvvaccineintheunitedstates20062015aneedforevidencebasedpolicy AT stolermarkh legislativeactivityrelatedtothehumanpapillomavirushpvvaccineintheunitedstates20062015aneedforevidencebasedpolicy AT kennedychristine legislativeactivityrelatedtothehumanpapillomavirushpvvaccineintheunitedstates20062015aneedforevidencebasedpolicy |